Can natural killer cells cure leukemia?
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B‑cells that arises from malignant transformation driven by B‑cell receptor signaling and genetic alterations, leading to the accumulation of small, mature‑appearing lymphocytes in blood, marrow and lymphoid tissues.
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
- Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review
- Immunotherapy for leukemia may change the bone marrow environment, cancer researchers find
- Next-generation CAR‑T therapy for acute myeloid leukemia: bridging innovation with clinical translation
- Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology